🇺🇸 FDA
Patent

US 9833427

Creatine ester anti-inflammatory compounds and formulations

granted A61KA61K31/22A61K31/66

Quick answer

US patent 9833427 (Creatine ester anti-inflammatory compounds and formulations) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/22, A61K31/66, A61P, A61P29/00